STAT3 and lung carcinoma: Interestingly, blockade of the AT1-R with losartan inhibited the expression of phospho(Tyr705)-STAT3 (Fig. 9C) in lung cancer cells, suggesting that STAT3 activation is, at least in part, dependent upon activation of the AT1-R.